Search Results - Ron Milo
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
What fraction of cellular DNA turnover becomes cfDNA? by Ron Sender, Elad Noor, Ron Milo, Yuval Dor
Published in eLife (2024-02-01)Get full text
Article -
2
-
3
-
4
-
5
-
6
-
7
The unmitigated profile of COVID-19 infectiousness by Ron Sender, Yinon Bar-On, Sang Woo Park, Elad Noor, Jonathan Dushoff, Ron Milo
Published in eLife (2022-08-01)Get full text
Article -
8
-
9
Steady-state metabolite concentrations reflect a balance between maximizing enzyme efficiency and minimizing total metabolite load. by Naama Tepper, Elad Noor, Daniel Amador-Noguez, Hulda S Haraldsdóttir, Ron Milo, Josh Rabinowitz, Wolfram Liebermeister, Tomer Shlomi
Published in PLoS ONE (2013-01-01)Get full text
Article -
10
Dynamic proteomics of human protein level and localization across the cell cycle. by Shlomit Farkash-Amar, Eran Eden, Ariel Cohen, Naama Geva-Zatorsky, Lydia Cohen, Ron Milo, Alex Sigal, Tamar Danon, Uri Alon
Published in PLoS ONE (2012-01-01)Get full text
Article -
11
Noise genetics: inferring protein function by correlating phenotype with protein levels and localization in individual human cells. by Shlomit Farkash-Amar, Anat Zimmer, Eran Eden, Ariel Cohen, Naama Geva-Zatorsky, Lydia Cohen, Ron Milo, Alex Sigal, Tamar Danon, Uri Alon
Published in PLoS Genetics (2014-03-01)Get full text
Article -
12
Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster by Ofra Amir, Yair Goldberg, Micha Mandel, Yinon M. Bar-On, Omri Bodenheimer, Laurence Freedman, Sharon Alroy-Preis, Nachman Ash, Amit Huppert, Ron Milo
Published in Communications Biology (2023-03-01)Get full text
Article -
13
Demonstration of bioplastic production from CO2 and formate using the reductive glycine pathway in E. coli. by Daria Fedorova, Roee Ben-Nissan, Eliya Milshtein, Cassandra Reyes, Ghil Jona, Nili Dezorella, Gil Feiguelman, Rostislav Fedorov, Aya Gomaa, Ariel B Lindner, Elad Noor, Ron Milo
Published in PLoS ONE (2025-01-01)Get full text
Article -
14
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosis. by Laura Bellassen, Keren David, Bar Lampert, Avital Sarusi-Portuguez, Michael Tsoory, Jazz Lubliner, Eran Hornstein, Michael Osherov, Ron Milo, Ori Brenner, Shirly Becker-Herman, Idit Shachar
Published in PLoS Biology (2025-09-01)Get full text
Article -
15
Demonstration of bioplastic production from CO2 and formate using the reductive glycine pathway in E. coli by Daria Fedorova, Roee Ben-Nissan, Eliya Milshtein, Cassandra Reyes, Ghil Jona, Nili Dezorella, Gil Feiguelman, Rostislav Fedorov, Aya Gomaa, Ariel B. Lindner, Elad Noor, Ron Milo
Published in PLoS ONE (2025-01-01)Get full text
Article -
16
B cell targeted therapies in inflammatory autoimmune disease of the central nervous system by Moritz J. Furman, Sven G. Meuth, Philipp Albrecht, Philipp Albrecht, Michael Dietrich, Heike Blum, Jan Mares, Ron Milo, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung
Published in Frontiers in Immunology (2023-03-01)Get full text
Article -
17
Promoters maintain their relative activity levels under different growth conditions by Leeat Keren, Ora Zackay, Maya Lotan‐Pompan, Uri Barenholz, Erez Dekel, Vered Sasson, Guy Aidelberg, Anat Bren, Danny Zeevi, Adina Weinberger, Uri Alon, Ron Milo, Eran Segal
Published in Molecular Systems Biology (2013-10-01)Get full text
Article -
18
Autotrophic growth of Escherichia coli is achieved by a small number of genetic changes by Roee Ben Nissan, Eliya Milshtein, Vanessa Pahl, Benoit de Pins, Ghil Jona, Dikla Levi, Hadas Yung, Noga Nir, Dolev Ezra, Shmuel Gleizer, Hannes Link, Elad Noor, Ron Milo
Published in eLife (2024-02-01)Get full text
Article -
19
Functional reconstitution of a bacterial CO2 concentrating mechanism in Escherichia coli by Avi I Flamholz, Eli Dugan, Cecilia Blikstad, Shmuel Gleizer, Roee Ben-Nissan, Shira Amram, Niv Antonovsky, Sumedha Ravishankar, Elad Noor, Arren Bar-Even, Ron Milo, David F Savage
Published in eLife (2020-10-01)Get full text
Article -
20
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment by Stephen L. Hauser, Ludwig Kappos, Amit Bar-Or, Heinz Wiendl, David Paling, Mitzi Williams, Ralf Gold, Andrew Chan, Ron Milo, Ayan Das Gupta, Goeril Karlsson, Roseanne Sullivan, Gordon Graham, Martin Merschhemke, Dieter A. Häring, Patrick Vermersch
Published in Neurology and Therapy (2023-07-01)Get full text
Article
